Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Friday 03 February, 2012

BAA Limited

Publication of Prospectus Supplement

RNS Number : 8148W
BAA Limited
03 February 2012

Not for release, publication or distribution in whole or in part, directly or indirectly, in or into the United States of America.


Publication of Prospectus Supplement


The following prospectus supplement (the "Prospectus Supplement") to the base prospectus dated 16 June 2011 (the "Prospectus") has been approved by the UK Listing Authority and is available for viewing:


BAA Funding Limited: Multicurrency programme for the issuance of Bonds


To view the full document, please paste the following URL into the address bar of your browser.





Copies of the Prospectus Supplement will shortly be available for inspection on the National Storage Mechanism (


For further information, please contact


Investor enquiries

Andrew Efiong, Head of Debt Investor Relations  020 8745 2742






Please note that the information contained in the Prospectus Supplement may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus is not addressed. Prior to relying on the information contained in the Prospectus you must ascertain from the Prospectus whether or not you are part of the intended addressees of the information contained therein.


Your right to access this service is conditional upon complying with the above requirement.  


This announcement does not contain or constitute an offer of, or the solicitation of an offer to buy or subscribe for, securities to any person in Australia, Canada, Japan or the United States or in any jurisdiction in which such offer or solicitation is unlawful. The securities referred to herein may not be offered or sold in the United States absent registration under the US Securities Act of 1933, as amended (the "Securities Act") except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. Subject to certain exceptions, the securities referred to herein may not be offered or sold in Australia, Canada or Japan or to, or for the account or benefit of, any national, resident or citizen of Australia, Canada or Japan. The offer and sale of the securities referred to herein has not been and will not be registered under the Securities Act or under the applicable securities laws of Australia, Canada or Japan. There will be no public offer of the securities in the United States.

This announcement is not a prospectus but constitutes an advertisement in respect of the New Securities for the purposes of the United Kingdom Financial Services Authority's ("UKLA") prospectus rules. The Prospectus has been made available to the public in accordance with EU Directive 2003/71/EC (the "Prospectus Directive") and/or Part VI of the Financial Services and Markets Act 2000 (the "FSMA"). Investors should not subscribe for any securities referred to herein except on the basis of information contained in the Prospectus.


This information is provided by RNS
The company news service from the London Stock Exchange

a d v e r t i s e m e n t